Skip to content

Clinical trials

Phase 2 Pulmonary Eosinophilia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Eosinophilia Phase: Phase 2 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20171
20181
20191
20201
20221
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Not yet recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Advagene Biopharma Co. Ltd.1
AnaptysBio, Inc.1
Chemlmmune Therapeutics LLC1
Chiesi Farmaceutici S.p.A.1
GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.1
GlaxoSmithKline1
Knopp Biosciences1
Kymera Therapeutics, Inc.1
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Eosinophilia9
Asthma5

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.